More than 4 million U.S. adults have glaucoma, about 35% have related vision loss
A study published in JAMA Ophthalmology estimated that 4.22 million U.S. adults…
Pfizer’s activist troubles, gene therapy questions, RFK Jr.’s MAHA ambitions
This week's episode of "The Readout LOUD" discusses the potential activist investor…
Sixty seconds on . . . fixing the NHS
The government has been focused on addressing issues with the healthcare system…
Gut microbe enzyme with surprising metabolic capabilities offers new therapeutic possibilities
Researchers at WashU School of Medicine have discovered a gut bacterial enzyme…
High-intensity workouts more effective at suppressing hunger in adults
A study published in the Journal of the Endocrine Society found that…
More Evidence Ties Semaglutide to Reduced Alzheimer’s Risk
A recent study suggests that glucagon-like peptide 1 receptor agonists, drugs used…
Curious About Your Aging? Here’s A Simple Test To Find Out
Researchers have found that standing on one leg is a better indicator…
The Convergence of Digital Health and Life Sciences
Digital health tools, such as telemedicine, personalized medicine, and healthcare data analytics,…
Johnson & Johnson Innovative Medicine expands immunology portfolio with Remicade (infliximab) and Simponi (golimumab) for treatment of Inflammatory diseases
Johnson & Johnson Innovative Medicine has taken over sales, marketing, and distribution…
Internal monologue and cognitive ability
Recent research has revealed that the experience of inner speech varies greatly…